Stian Westlake, director of research at the National Endowment for Science, Technology and the Arts, agrees that the trend towards open innovation means that instead of wooing a few high-profile investors, ministers must now wade through rules and regulations to ensure the UK nurtures the kinds of innovative start-ups where the most exciting R&D now takes place.
via The Observer.
How much of this is, as they claim, to do with
focusing our efforts…where we…can deliver the greatest medical and commercial impact
or with not believing in their ability to innovate in the UK rather than any burgeoning investment in University or “open” research?